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Abstract
Venous thromboembolism (VTE) is a serious health concern of patients undergoing
orthopedic surgery. Analysis of the study site semiannual reports from January 2014
through March 2015 indicated 10 VTE events in 546 orthopedic cases. The community
hospital was classed as an outlier performing in the bottom 10th percentile when
compared to other hospitals. To standardize the ordering of VTE prophylaxis, the hospital
developed a postoperative electronic VTE order set. The purpose of this project was to
assess the difference in orthopedic VTE occurrences in the postoperative total hip
arthroplasty (THA) patients before and after the implementation of the electronic VTE
order set. The goal of the project was to use an electronic retrospective chart review to
evaluate if the order set implementation influenced the adherence to ordering mechanical
and pharmacological prophylaxis in the THA patient. Differences in the ordering of VTE
prophylaxis and VTE outcomes were evaluated using a retrospective review of 325
preimplementation order set cases and 406 postimplementation order set cases. This
evaluation demonstrated that appropriate pharmacological prophylaxis ordering increased
and orthopedic VTE occurrences decreased after the standardized electronic order set was
implemented. Social change occurred through the empowerment of clinicians when
empirical evidence was provided for use at the point of care, which positively impacted
patient outcomes undergoing a common surgical procedure. VTE is no longer considered
a routine postoperative orthopedic complication as technology-enabled solutions have
proven to be appropriate tools to combat and prevent postoperative VTE complications.
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Section 1: Nature of the Project
Introduction
Venous thromboembolism (VTE) poses a significant health and economic burden
in U.S. hospitals (Merli, Ferrufino, Lin, Hussein, & Battleman, 2008). Orthopedic
procedures have been found to have the highest prevalence of deep vein thrombosis when
compared to other surgical procedures (Takai et al., 2013). The American College
Surgeons National Surgical Quality Improvement Project (ACSNSQIP) 2014 Semiannual
Report for the time period of January 2014–March 2015 reported 10 VTE events in 546
orthopedic cases. Based on the orthopedic VTE outcomes data, the study site hospital
was classed as an outlier performing in the bottom 10th percentile when compared to
other organizations.
Several years ago, the organization planned to improve orthopedic VTE outcomes
by standardizing practice with electronic order sets. Due to a series of unfortunate
circumstances, electronic order set activity for orthopedics was abruptly stopped. After
leadership changes and new priorities, the electronic order set project began again with
momentum to improve VTE outcomes. In July of 2014, the organization implemented
computerized provider order entry (CPOE) order sets for the orthopedic service line. The
purpose of this project was to assess the difference of orthopedic VTE occurrences in the
postoperative total hip arthroplasty (THA) patient before and after implementation of the
electronic VTE order set. In this study, I will discuss the factors that contributed to an
increase in VTE, the nature of the project, and provide a solution to decrease the
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incidence of VTE. In Section 1, I will discuss the context of the problem, project
objectives, project questions, the significance of the project, implications for social
change, and the assumptions and limitations.
Background and Context
The study site hospital organization is a regional tertiary facility comprised of 450
acute care beds and that employs over 900 nurses and a total of 4,500 employees. The
hospital earned Magnet designation in 2005 and received redesignation in 2009 and 2015
by the American Nurses Credentialing Center. The community identifies the organization
as a quality health care leader due to the fact it has received quality awards such as high
ranking in orthopedics by the U.S. News and World Report, Thomson Reuters Top 100
Cardiovascular Hospitals, Blue Distinction Award for Treatment of Complex and Rare
Cancers, Heart and Stroke Emergency Center Designation, Percutaneous Coronary
Intervention by Accreditation for Cardiovascular Excellence, and Best Hospital of the
Capital Region.
The organization underwent considerable change due to a local merger with three
smaller acute care hospitals, while being simultaneously involved in a large enterprisewide consolidation. The enterprise consolidation had established a ministry that employs
over 80,000 associates. The community hospital organization continues to focus on
delivering the highest quality comprehensive continuum of integrated health care services
in the region.
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The organization has been challenged with the integration of CPOE within their
patient care delivery model. Due to a higher than expected VTE rate, the orthopedic
specialty was chosen by the organization to implement electronic order sets. The ultimate
goal of CPOE was to standardize postoperative VTE prophylaxis ordering across the
specialty to reduce VTE outcomes in the orthopedic patient. The absence of standardized
electronic VTE order sets resulted in wide variation of VTE prophylaxis ordering on
paper-based order sets. Within the paper-based order set, a section was dedicated to VTE
prophylaxis. Some prophylaxis orders were predefined and other orders had blank lines
for providers to write in orders. Inconsistencies in the order sets resulted in varied VTE
prophylaxis ordering by providers. A number of factors will be discussed that contributed
to an increase in the rate of VTE in postoperative orthopedic patients.
Under the guidance of the enterprise, physician division chiefs, clinicians, and key
subject matter experts across 19 acute care hospitals came together to standardize the
postoperative orthopedic order set. The chief of orthopedics presented a persuasive
argument to design the electronic order set to be all inclusive and support the ordering of
VTE quality measures, which was supported by his orthopedic colleagues and
interdisciplinary team. Through this process, relationships across the hospital system
were fostered and strengthened within orthopedics. By the end of the order set design
sessions, the orthopedic teams were pleased with their final product and were anxious to
see the content be deployed in the electronic health record.

4
Weeks prior to releasing the order set for testing it was announced that the entire
enterprise team was no longer with the system office. The order set project had come to
an abrupt stop. Over the next couple of months, a new team was brought on-board to get
the project back on track. The philosophy of the new team was different. They did not
support an all-inclusive order set and insisted the order sets be pared down to specific
content and be supplemented with additional modular order sets.
Without input from key stakeholders, the new system office leaders pared down
the order set content and provided it to the chief of orthopedics. The VTE prophylaxis
orders had been removed from the larger order set and were moved to a subspecialty
folder named VTE prophylaxis that was not linked to the postoperative orthopedic order
set. The format was very concerning to the chief of orthopedics because it would require
the clinician to remember to use the VTE order set that is in a different area than the
postoperative orthopedic order set. The chief of orthopedics did not agree with order set
version and declined to accept and implement the electronic order set.
Eighteen months later, with a new chief of orthopedics the organization called
upon the leader to implement CPOE. CPOE was necessary for two reasons. First, the
VTE rate was higher than expected due to variation with paper orders. The pharmacy
department reported receiving paper-based orders without VTE prophylaxis being
ordered. When recognized, the pharmacy and nursing staff had to call providers for
resolution. Computerized order entry offered the opportunity to standardize VTE
prophylaxis ordering practices across orthopedics and improve VTE outcomes. The
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second reason was to assist the organization to meet Meaningful Use (MU) II. For
organizations to meet MU II, 60% of all medication orders had to be entered using CPOE
(Centers for Medicare & Medicaid Services [CMS], 2012). Electronic medication orders
were hovering at 48% which was below the 60% target. The significant volume of
orthopedics patients would increase electronic medication orders above the target. The
hospital organization convinced the system office to permit orthopedics to design a
custom mega order set to meet their needs.
During the development of the organization’s comprehensive postoperative
orthopedic order set, the content design team incorporated VTE prophylaxis order set
content for use in CPOE. The VTE prophylaxis content was developed with an
interdisciplinary team by referencing the latest national guidelines from the American
Academy of Orthopedic Surgeons (AAOS) and the American College of Chest
Physicians (ACCP). To ensure medications within the VTE prophylaxis order set were
well designed, the Institute for Safe Medication Practice’s guidelines for order sets served
as a style guide for the organization. The electronic order set content was vetted by the
chief of orthopedics and the orthopedic interdisciplinary team. After several edits, the
content was approved, signed off by the chief of orthopedics and submitted to the
enterprise health system. The order set was approved and built within the clinical
information system. Orthopedics went live with CPOE in July of 2014.
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Problem Statement
The postoperative orthopedic VTE data derived from the hospital’s ACSNSQIP
2014 Semiannual Report for the time period January 2014 to March 2015 reported 10
VTE events in 546 orthopedic cases. Based on the orthopedic VTE events reported, the
organization was performing in the bottom 10th percentile (National Surgical Quality
Improvement Project (NSQIP), 2015). Variation with paper-based order sets contributed
to an increase in VTE, so to standardize practice, in July of 2014 the organization
implemented CPOE to decrease orthopedic VTE outcomes. Since CPOE was
implemented, orthopedic VTE outcomes were higher than expected. It was been
determined that the electronic VTE prophylaxis protocol was not consistently used by
providers. The orders were entirely skipped or only a portion of the protocol may be
ordered. Both nursing and pharmacy identified errors of commission or omission with
VTE prophylaxis. The organization did not know what the negative impact of the
electronic order set was on the incidence of VTE.
The National Surgical Quality Improvement Project (NSQIP; n.d.) is a nationally
benchmarked, clinical, risk-adjusted, and outcomes-based program to measure and
improve care across surgical specialties nationally. The hospital organization’s quality
improvement plan initiative was to achieve a national benchmark performance in the 90th
percentile for variation prophylaxis ordering practices. Since the implementation of the
electronic VTE order set in July 2014, the organization did not assess if technology was
contributing to an increase or decrease in the number of orthopedic VTE events. It was
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important for the organization to appraise if there were any unintended consequences
posed by not using the order set properly.
Purpose Statement
The purpose of this project was to assess the difference of orthopedic VTE
occurrences in the postoperative THA patient before and after the implementation of the
electronic VTE order set. In July 2014, the organization implemented electronic order
sets for the postoperative orthopedic patient population. In an effort to align the electronic
VTE order set content with the most recent clinical practice guidelines established by the
AAOS, ACCP, and CMS MU requirements, the VTE prophylaxis order sets were
embedded into the comprehensive admission postoperative orthopedic order set. The allinclusive or mega order set approach was designed to support accurate ordering practices
without having to leave the order set. Additionally, the approach was developed to
augment clinician workflow and to encourage the ordering of important care
requirements such as VTE prophylaxis for all postoperative orthopedic patients.
The NSQIP VTE events that occurred between January 2014–March 2015
comprised paper-based orders sets prior to July 1, 2014 and electronic order sets
thereafter. During the electronic order set go-live in July 2014, clinical informatics
nurses’ at-the-elbow support was embedded in the Post Anesthesia Care Unit (PACU) to
hardwire the new electronic order entry process and workflow for orthopedic providers.
Adapting to new electronic workflow took time for clinicians. The transition from paper
to electronic order entry resulted in both paper-based and electronic order entry of VTE
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prophylaxis until the new workflow was hardwired and adopted. Order set utilization
rates measured by the hospital demonstrated strong adoption of CPOE by the providers;
however, the organization had not mandated providers to use CPOE.
Project Objectives
I had two project objectives for this DNP project. My first objective was to
evaluate if technology influenced the adherence to ordering of mechanical prophylaxis in
the THA patient. I reviewed each THA case to assess the adherence to ordering
mechanical prophylaxis. Ordering adherence was measured by developing a tool that
included patient demographic information and the type of mechanical prophylaxis
ordered. To assess aspects of mechanical VTE guidelines, a comparison of the percent of
adherence before and after implementation of the order set was calculated to evaluate if
technology was affecting VTE occurrences.
My second objective was to evaluate if technology influenced the adherence to
ordering pharmacological prophylaxis in the THA patient. I measured ordering adherence
by developing a tool that included patient demographic information and the type of
pharmacological prophylaxis ordered. To assess aspects of pharmacological VTE
guidelines, a comparison of the percent of adherence before and after implementation of
the order set was calculated to evaluate if technology is affecting VTE occurrences.
In this project, I defined the electronic VTE order set preimplementation period as
January 1–June 30, 2014. The electronic VTE order set postimplementation period was
defined as January 1–June 30, 2015. All THA cases during the two time periods defined
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were provided by Stryker. Stryker is a contracted vendor that specializes in collecting
patient reported outcomes and extracting important hospital metrics into a dashboard to
evaluate opportunities for process improvement (Stryker Performance Solutions, 2013).
White and Dudley-Brown (2012) affirmed that outcomes data are crucial for
providers to better understand the effects their services have on the patients they provide
care for. The hospital organization’s latest orthopedic VTE outcomes performance
suggested there was a problem with VTE occurrences in the postoperative THA patient.
After the implementation of the electronic order set, the anticipated outcomes included:
(a) an increase in the ordering of VTE prophylaxis in the post-operative THA patient, (b)
an increase in the adherence to mechanical and pharmacological prophylaxis guidelines
in the postoperative THA patient, and (c) a decrease in VTE occurrence for postoperative
orthopedic THA patients. My review of the VTE outcomes assisted in the analysis of
technology strategies to support the translation of the latest VTE guideline
recommendations into evidence-based practice.
Project Questions
Given the objectives of the project, I developed the following four questions to
guide the study:
1. “What is the difference in the ordering of VTE prophylaxis before and
after implementation of the electronic order”?
2. “What is the difference in ordering of mechanical prophylaxis before and
after implementation of the electronic order set”?
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3. “What is the difference in the ordering of pharmacological prophylaxis
before and after implementation of the electronic order set”?
4. “What is the difference in orthopedic VTE occurrences before and after
implementation of the electronic order set”?
During the development of the electronic order set content, there was debate over
the most appropriate prophylaxis interventions for the THA patient. While the AAOS and
ACCP guidelines were utilized to develop the electronic VTE prophylaxis order set, the
grade of evidence for some recommendations were stronger than others, limited, or
inconclusive. An evaluation of the electronic VTE order set compared to the
recommendations of both national organizations was needed to ensure the order set was
aligned to support clinicians in adhering to evidence-based practice. Completing an
analysis of postoperative THA patients that developed a VTE was beneficial to assess
common themes contributing to the development of VTE. Inconsistencies in the ordering
of VTE prophylaxis may have influenced providers to adhere to the guidelines of one
nationally recognized organization over another and alter their current VTE prophylaxis
regimens.
Significance of the Project
When an organization commits to the philosophy of evidence-based practice, they
are positioning themselves to deliver high quality care that is cost effective (White &
Dudley-Brown, 2012). Despite good evidence, it is difficult work to drill into practice
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changes that may improve patient safety. Within systems of care, knowledge translation
needs to occur (White & Dudley-Brown, 2012).
According to Pronovost et al. (2009), “the boundaries between safety and the
broader concept of quality remain poorly defined” (p. 330). In an effort to clarify broad
clinical and policy domains that link to a safety scorecard, Pronovost et al. developed a
Framework for Patient Safety Research and Improvement. The five framework domains
include evaluating progress in patient safety, translating evidence into practice,
measuring and improving culture, identifying and mitigating hazards, and evaluating the
association between organizational characteristics and outcomes (Pronovost et al., 2009).
Furthermore, Pronovost et al. argued that most research funding is spent on
understanding disease mechanisms while there has been little research dedicated to
identify effective, efficient, and safe delivery of care to patients.
Doctoral-prepared nurses must be prudent financial stewards to reduce the cost of
care for patients and health care organizations. Expanding an individual’s scope of
knowledge related to the economics of healthcare will require continuous appraisal of the
literature to stay current with newly proposed financial models such as value-based
purchasing, which incorporate safe reliable care delivery where value is a function of
both quality and cost (CMS, 2014a). Using technology solutions to assist in decreasing
VTE occurrences in the postoperative THA patient improved quality outcomes,
decreased cost, and ensured care that was both dependable and reliable.
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Reduction of Gaps
The Agency for Healthcare Research and Quality (AHRQ; 2014a) reported deep
vein thrombosis (DVT) may increase hospital length of stay by 2 to 5 days and result in
excess costs of about $7,500. Pulmonary embolism (PE) can increase hospital length of
stay by more than 5 days, result in an intensive care unit admission, and incur additional
costs of more than $10,000 (AHRQ, 2014a). After a major surgical procedure, the risk of
DVT and PE is approximately 20% for patients that did not receive prophylaxis (Baser,
2011). If patients do not receive the appropriate prophylaxis, patient safety issues, poor
outcomes, and financial implications for the organization could be incurred.
The number one strategy to improve patient safety for patients at risk of VTE is
the use of appropriate prophylaxis (AHRQ, 2014a). To ensure appropriate prophylaxis is
utilized, clinicians must adhere to clinically appropriate evidence-based methods of
prophylaxis. The AAOS (2011b) and ACCP (2012) both provide lengthy guidelines on
the prevention and management of VTE prevention including suggestions for individual
assessment of patients when choosing the specific thromboprophylaxis strategy. The
hospital organization did not evaluate if the electronic VTE prophylaxis order set content
was aligned to support the provider in selecting the most appropriate thromboprophylaxis
based on AAOS or ACCP guidelines. Additionally, cases were not reviewed to identify
themes for patients that developed a VTE following elective hip arthroplasty.
A retrospective content review of VTE cases for the elective hip arthroplasty
population can provide insight into the adherence to national guidelines,
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thromboprophylaxis ordering patterns, and assist in the detection of errors of omission
and commission. To determine if the actual practice of thromboprophylaxis ordering was
consistent with AAOS and ACCP recommendations, I expected the project to reveal
where variation and/or deviation from the order set existed when ordering VTE
prophylaxis, the patient specific risk of VTE, and if the prophylaxis was aligned with
either AAOS or ACCP evidence-based guidelines.
Implications for Social Change
VTE is a serious health concern. Beckman, Hooper, Critchley, and Ortel (2010)
acknowledged known risk factors such as increased age, immobility, surgery, and obesity
are a public health problem that needs attention. In 2007, within six European countries, a
total of 465,715 cases of DVT and 295,982 cases of PE were estimated (Cohen et al.,
2007). Of the combined cases, deaths related to VTE were 370,012 or 49% (Cohen et al.,
2007). More recent data in the United States indicates 900,000 people are affected by
VTE each year and nearly 300,000 die from the disease (Dasta et al., 2015). By 2050, the
number of adults with VTE is estimated to double to 1.82 million in the United States
(Dasta et al., 2015). Despite efforts to increase awareness of VTE, health care providers
can underrecognize the condition.
The ultimate goal of this project was to assess if the electronic order set
influenced the provider’s adherence to ordering VTE prophylaxis and decreased VTE in
the THA patient. VTE is preventable and needs to be taken seriously. With this project, I
sought to inform providers that inconsistent use of the order set contributed to a delay or
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omission in prophylaxis ordering. Providers needed to assess their current practice and
consider effective approaches to promote best practice prophylaxis use and prevent
patient harm resulting from VTE.
The social change realized across the organization was that unsafe medical care is
not acceptable. Patients should not be harmed when receiving care in the organization. It
was necessary for healthcare providers to learn more about the burden and causes of VTE
and adopt best practices to ensure safe patient care. Accepting VTE as a routine
postoperative surgical or orthopedic complication is no longer acceptable. Raising public
awareness and developing a comprehensive public health approach that leverages
technology to combat and prevent VTE could reduce complications and unnecessary
deaths. Developing a comprehensive training module for clinicians, patients, and families
on VTE prevention could be the first step to raise awareness and engage the public to
understand why VTE prevention is critical for improvements in patient outcomes.
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Definition of Terms
In the healthcare field, many terms are commonly used. Depending on the context
of the information, terms can be misinterpreted or have more than one meaning. In the
following subsection, I will define the terms referenced throughout the project study:
American Recovery and Reinvestment Act (ARRA): An act passed in 2009, that
earmarked $22 billion for the adoption of electronic health records (EHRs), with a goal of
100% adoption in all practice settings by the year 2014 (The White House, 2009).
Computerized provider order entry (CPOE): The process of entering medication
orders and other physician’s instructions electronically using a computer-based system to
ensure standardized, legible, and complete orders (Al-Dorzi et al., 2011, p.1).
Deep vein thrombosis (DVT): Formation of one or more blood clots in the body’s
large veins, most commonly the lower leg or calf (Office of the Surgeon General;
National Heart, Lung, and Blood Institute, 2008).
Electronic health record (EHR): An electronic version of a patient’s medical
history that is maintained by the provider over time and may include all of the key
administrative clinical data relevant to that persons care under a particular provider,
including demographics, progress notes, problems, medications, vital signs, past medical
history, immunizations, laboratory data, and radiology reports (CMS, 2012, para. 1).
Health information technology (HIT): A broad concept that encompasses an array
of technologies to store, share and analyze health information (U.S. Department of Health
& Human Service, 2013).

16

Hospital acquired condition (HAC): A medical condition or complication that a
patient develops during the hospital stay, which was not present on admission (CMS,
2015b).
Intermittent pneumatic compression device (IPCD): An inflatable cuff wrapped
around the leg with an electrical pneumatic pump that inflates the cuff with air to increase
femoral venous blood flow and venous emptying (Fujisawa, Naito, Asayama, Kambe, &
Koga, 2003);
Meaningful use (MU): Using certified EHR technology to improve quality, reduce
health disparities, engage patients and family, improve care coordination and population
health, and maintain privacy and security of patient health information (U.S. Department
of Health & Human Services, 2015).
Order set: Grouping of common predefined orders for a particular disease state
(Cowden, Barbacioru, Kahwash, & Saltz, 2003).
Pulmonary embolism (PE): A portion of a blood clot breaks loose and travels into
the blood stream, first to the heart and then to the lungs, where it can partially or
completely block a pulmonary artery or one of its branches (Office of the Surgeon
General ; National Heart, Lung, and Blood Institute, 2008).
Total hip arthroplasty (THA): A surgical procedure where the damaged bone and
cartilage is removed and replaced with prosthetic components (American Academy of
Orthopedic Surgeons, 2015).
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Venous thromboembolism (VTE): DVT and PE are grouped together and referred
to as VTE (Office of the Surgeon General; National Heart, Lung, and Blood Institute,
2008).
Assumptions and Limitations
As I developed and conducted the project, it was important to plan for and address
assumptions. Assumptions are external factors that have the potential to influence the
success of the project but are outside the control of the project leader (White & DudleyBrown, 2012). My first assumption for this DNP project was that the order set has a
positive influence on provider ordering practices for VTE prophylaxis. A second
assumption was the order set has been fully adopted by the providers with 100%
utilization of the electronic order set. My third assumption was that when used properly,
the order set will decrease VTE in THA patients.
Limitations of the project included the fact that a 6-month period was reviewed
before and after the implementation of the electronic order set to assess the difference in
the occurrence of orthopedic VTE. A longer time period to evaluate the differences in the
occurrence of orthopedic VTE may have been beneficial. Another limitation was the
hospital organization had not mandated providers use CPOE. Encouraging providers to
use CPOE was important to the project. Educating providers on measures of efficiency,
such as medication turnaround time or time to first dose of prophylaxis, will be essential
to demonstrate adoption of the order set (Classen, Avery, & Bates, 2007). A third
limitation was when using the order set there was no alerting mechanism to the provider
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if VTE prophylaxis was not ordered. The project identified that additional clinical
decision support may be beneficial to ensure prophylaxis has been ordered.
Summary
Although preventable, VTE continues to be a major concern in the United States.
Following orthopedic surgery, VTE is the leading cause of hospital readmission (Johnson
& Riley, 2012). With the purpose of decreasing VTE, the hospital organization study site
chose to standardize and drive practice improvements with electronic order sets. In this
project, I conducted a comparison of VTE occurrences before and after implementation
of the order set. The results of the project informed the organization that the electronic
order set is working as designed to improve practice. The analysis I conducted revealed
mechanical prophylaxis remained the same while the pharmacological prophylaxis
increased, which resulted in a decrease of orthopedic VTE outcomes. Evaluating the
impact of electronic order sets has led to safer and more reliable hospital and postacute
care for orthopedic patients.
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Section 2: Review of Scholarly Evidence
Introduction
Section 2 will include the literature review. In this specific literature review, I will
discuss the pathophysiology, assessment, and risk factors of VTE in the postoperative
orthopedic population. The past lack of evidence to recommend chemical prophylaxis
and the more current emerging evidence demonstrating the efficacy of aspirin,
enoxaparin, and IPCDs to prevent VTE in postoperative joint replacement surgery will
also be discussed. The general literature review will also include a focused review of the
AAOS and ACCP VTE prophylaxis recommendations for aspirin, enoxaparin, and IPCDs
in the postoperative orthopedic population. The AAOS and ACCP are two nationallyrecognized organizations that publish evidence-based clinical practice guidelines on
preventing VTE disease in patients undergoing elective joint replacement surgery. In the
general literature review, I will also discuss how CPOE and order sets can standardize
VTE care, decrease variation, and improve patient outcomes. Lastly, I will use an
accountable care organization (ACO) model to explore the problem of VTE in the
postoperative orthopedic THA patient population and foster shared accountability among
providers for the quality and cost of care.
Search Strategy
To perform the literature review, I accessed the following databases and libraries:
AHRQ, OVID Technologies, Medline, PubMed Medline, Institute of Medicine (IOM),
ProQuest Nursing and Allied Health Sources, Cumulative Index to Nursing and Allied
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Health Literature (CINAHL), EBSCOhost, AAOS, ACCP, and the National Guideline
Clearinghouse. Key search terms for the literature review included: venous
thromboembolism prophylaxis in orthopedic surgery, venous thromboembolism in total
joint arthroplasty, venous thromboembolism in total hip arthroplasty and replacement,
chemical prophylaxis in orthopedics, aspirin use in orthopedics, enoxaparin use in
orthopedics, mechanical prophylaxis, intermittent pneumatic compression devices,
clinical information systems, physician order entry, computerized provider order entry,
electronic order sets, venous thromboembolism orthopedic AND hip arthroplasty, aspirin
AND orthopedic surgery, aspirin AND total hip replacement, enoxaparin AND
orthopedic surgery, enoxaparin AND total hip replacement, mechanical prophylaxis
AND total hip replacement, and electronic order sets AND venous thromboembolism
prophylaxis OR total hip arthroplasty.
In the review, I located 65 articles. Twenty-five articles were rejected due to lack
of pertinent information to the project. Forty studies I found included in the literature had
publication dates from 1986 to 2015. The methodologies in the articles included classical,
comparative, meta-analysis, randomized control trials, review, and systematic reviews.
The content included controversy over using chemical prophylaxis versus aspirin to
prevent VTE in major orthopedic surgery, the use of enoxaparin and intermittent
pneumatic compression devices in the prevention of postoperative VTE in major
orthopedic surgery, AAOS and ACCP national guidelines and recommendations to
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prevent postoperative VTE in major orthopedic surgery, and the benefits of clinical
information systems and electronic order sets to standardize physician practice.
Review of Literature
The clinical practice of prescribing thromboprophylaxis by orthopedic surgeons
following THA surgery is not standardized. Within the last 10 years, hospital oversight
groups require hospitals to monitor and report orthopedic VTE rates (AHRQ, 2014a).
Improving VTE rates has prompted hospitals to work with orthopedic surgeons to
implement evidence-based practices that can be standardized and hard wired within
clinical information systems (Cohen et al., 2007). Guidelines published by the AAOS and
ACCP are broad and provide multiple options for pharmacological prophylaxis. After
reviewing the guidelines, orthopedic surgeons may have differing opinions on which type
of chemical prophylaxis to order following surgery. I will discuss the literature produced
within the last 20 years as it has long been debated.
Pathophysiology of Venous Thromboembolism (VTE)
Abnormal blood flow, blood vessel wall, and blood clotting components, known
jointly as Virchow’s triad can cause the formation of thrombus (Turpie, Chin, & Lip,
2002). Prolonged periods of immobility or confined bed rest can result in blood flow
abnormalities or venous stasis (Turpie, Chin, & Lip, 2002). One of the extrinsic factors
triggering the clotting cascade is damage to the epithelial cell lining if the blood vessel
(Snyder, 2008). As blood clots develop “the damaged endothelium attempts to maintain
vascular integrity by adhesion and aggregation of platelets” (Snyder, 2008, p. 225). As
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clotting progresses, the final step is the formation of thrombin, which leads to the
conversion of fibrinogen to fibrin and the formation of a fibrin clot (Arcangelo &
Peterson, 2006).
Pain, erythema, tenderness, and swelling of the affected extremity are common
signs of DVT. DVT of the lower extremity is usually swollen with the circumference of
the calf larger than the unaffected calf (Turpie, Chin & Lip, 2002). Compression
ultrasonography is the noninvasive test of choice to confirm the diagnosis of clinicallysuspected DVT (Turpie, Chip & Lip, 2002). Sudden shortness of breath, pleuritic chest
pain, or collapse with shock in the absence of other causes are common signs of PE
(Snyder, 2008). If thrombus separate from the vessel wall, it becomes an embolus
(Turpie, Chin & Lip, 2002). The clot travels through the circulation until it lodges in a
blood vessel where the blood flow is blocked and tissues or organs are deprived of
oxygen (Snyder, 2008). PE is one the most serious complications in the orthopedic
surgery population (AHRQ, 2014b). Pulmonary angiography testing is the gold standard
to confirm the diagnosis of clinically-suspected PE (Turpie, Chin & Lip, 2002).
Venous Thromboembolism (VTE) Assessment and Risk Factors
With major orthopedic surgery, VTE is considered an important complication that
is associated with significant morbidity and mortality (Cionac Florescu et al., 2013).
Orthopedic patients are more vulnerable to VTE due to several prothrombotic processes
such as: coagulation activation from tissue and bone injury, venous injuries, heat due to
cement polymerization, reduced emptying intra-or postsurgery, and immobilization
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(Cionac Florescu et al., 2013). In the absence of prophylaxis almost half of the patients
undergoing elective total hip or knee replacement surgery develop VTE (Anderson &
Spencer, 2003). PE is the most common postoperative complication in THA and is
attributed to half of the postoperative deaths (Cionac Florescu et al., 2013).
Unique to orthopedic surgery is that the VTE risk period begins at surgery and
extends beyond hospitalization into the postacute care setting, which prolongs the period
of thromboprophylaxis (Cionac Florescu et al., 2013). Thrombus formation can take
several days or weeks and is often detected days or weeks after hospital discharge
(Snyder, 2008). Cohen et al. (2008) argued that despite the availability of evidence-based
guidelines for VTE prophylaxis, assessment of patients who may be at risk is not
consistently undertaken at both international and national levels. Currently, there is no
way to predict which postoperative orthopedic patients will develop VTE. Educating
patients and their care givers on the signs and symptoms of VTE may provide a public
health benefit.
Risk factors for VTE should be evaluated by the orthopedic surgeon prior to
arthroplasty surgery. While the literature is not specific for VTE risk factors in THA
patients, there is strong evidence of overall VTE risk factors that include age greater than
50, myeloproliferative disorder, dehydration, congestive heart failure, active malignancy,
hormonal replacement, moderate to major surgery, prior history of VTE, impaired
mobility, inflammatory bowel disease, active rheumatic disease, sickle cell disease,
estrogen-based contraceptives, central venous catheter, acute or chronic lung disease,
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obesity, known thrombophilic state, varicose veins/chronic stasis, recent postpartum with
immobility, nephrotic syndrome, and myocardial infarction (AHRQ, 2014a). The
presence of these risk factors emphasizes the importance of individualized VTE risk
assessment. A prior history of VTE and undergoing elective hip or knee arthroplasty
surgery may present the highest risk of VTE in orthopedic patients (Cohen et al., 2007).
An important aspect in the prevention and management of VTE is assessing
patient risk for both VTE and bleeding in the preoperative period (Beckman, Hooper,
Critchley, & Ortel, 2010). Data from the VTE assessment can be used to modify the type
of VTE prophylaxis for optimal patient safety (Cohen et al., 2007). Regardless of patient
factors, surgical procedure factors, such as length of surgery, presence of trauma, and
orthopedic surgery, can have a significant impact on the risk of VTE (Dasta et al., 2015).
Although no single VTE risk assessment has been prospectively validated as superior to
another (AHRQ, 2014a), the Caprini VTE risk assessment is frequently used for surgical
patients. I did not find a VTE risk assessment specifically tailored to orthopedic surgery
patients in the literature. The Caprini VTE risk assessment is a point-based tool that is
used to assess risk factors for the development of VTE in surgical patients (AHRQ,
2014a). The results of the score can be used by providers to stratify VTE risk and
determine the type of prophylaxis for surgical patients.
Bleeding is considered a major potential complication of chemical prophylaxis
and requires careful evaluation by the provider (Cohen et al., 2007). Types of VTE
prophylaxis used during hospitalization include chemical and mechanical prophylaxis.
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Chemical prophylaxis includes low-molecular-weight heparin, unfractionated heparin,
vitamin K antagonist, fondaparinux, and antiplatelet agents (AHRQ, 2014a). Mechanical
prophylaxis includes intermittent pneumatic compression, venous foot pumps, and
graduated compression stockings (Cohen et al., 2008). Mechanical prophylaxis devices
can reduce the formation of blood clots by increasing blood flow (Collins, MacLellan,
Gibbs, MacLellan, & Fletcher, 2010). Pharmacological and mechanical prophylaxis can
be used in combination for patients with increased VTE risk factors (AHRQ, 2014a).
Traditionally, providers have been responsible for assessment and prescribing
VTE prophylaxis, while nursing’s role has been limited (Collins et al., 2010). Nurses that
are involved in direct patient care can have a pivotal role in the assessment and
prevention of VTE. In the immediate postoperative period, nurses are providing direct
patient care and conducting detailed patient assessments to ensure the patient is
responding appropriately. If nurses are educated on the latest evidence-based practices in
the assessment and prevention of VTE they can have a prominent role in changing
practice to promote optimal patient outcomes.
Lack of Evidence to Recommend Chemical Prophylaxis
Warwick, Williams, and Bannister (1995) analyzed the records of 1,162 patients
who had a primary or revision THR performed between 1990 –1991. The purpose of their
study was to determine the frequency of fatal and nonfatal PE and DVT 6 months after
surgery. Routine chemical prophylaxis was not used during this time; antiembolic
stockings and early mobilization was the standard practice (Cohen et al., 2008). Of the
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1,162 patients, four or .34% developed fatal PE, 14 or 1.2% developed symptomatic PE,
and 22 or 1.89% developed DVT (Warwick et al., 1995). The researchers concluded that
in the absence of routine chemical prophylaxis, the fatal PE rate was low after total hip
replacement (THR) (Warwick et al., 1995). The results of the study did not provide
sufficient evidence to recommend thromboprophylaxis after hospital discharge. The large
cohort of 1,162 patients that were treated by 12 consultant surgical teams at one
specialized center would be considered a strength of the study. Evaluating the results of
this study could contribute to orthopedic surgeons’ reluctance to ordering chemical
prophylaxis within the standardized electronic order set. The results of Warwick et al.’s
study support this project because thromboembolism prophylaxis in total hip replacement
surgery has been a controversial issue with orthopedic surgeons. Within the hospital
organization study site, orthopedic surgeons had differing opinions over which agent to
use routinely for chemical prophylaxis. To promote routine use of chemical prophylaxis
an electronic order set was developed.
Fender, Harper, Thompson, and Gregg (1997) found that the use of chemical
prophylaxis did not affect the overall mortality or fatal PE rates. Of the 1,893
arthroplasties, 1,226 or 64.8% received some form of chemical prophylaxis and 667 or
35.2% received no chemical prophylaxis (Fender, Harper, Thompson & Gregg, 1997).
For those with chemical prophylaxis, the mortality rate was 10 of 1,226 or .82% and
seven of 667 or 1.05% for those without chemical prophylaxis (Fender, Harper,
Thompson & Gregg, 1997). For those with chemical prophylaxis, the PE rate was 3 of
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1,226 or .24% and 1 of 667 or .15% for those without chemical prophylaxis. The study
concluded that with the use of chemical prophylaxis, there was no significant difference
between mortality and PE rates. The type of chemical prophylaxis patients received is not
reported in the study. Since patients were not randomized into a specific group with
chemical prophylaxis there is no comparison of mortality and PE rates with other
chemical prophylaxis agents. Evaluating the results of this study could contribute to
orthopedic surgeon’s reluctance to ordering chemical prophylaxis within the standardized
electronic order set. The study supports the controversial matter that chemical
prophylaxis may not have an impact on the incidence of VTE. For orthopedic surgeons
practicing in the 1990s, the literature was not conclusive in demonstrating the efficacy of
routine use of chemical prophylaxis to prevent VTE in total hip replacement surgery.
Given the controversial issues, the organization reviewed recent literature and guidelines
to develop evidence-based electronic order sets.
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Efficacy of Aspirin to Decrease Venous Thromboembolism
During 1992 through 1998, 4,088 patients undergoing elective arthroplasty were
randomized into the placebo-controlled group and into the aspirin group of the pulmonary
embolism prevention (PEP) trial (PEP Trial Collaborative Group, 2000). The PEP study
is considered a large and important study of aspirin after major orthopedic surgery. The
purpose of the study was to prove or disprove if 160 mg of aspirin daily reduces the risk
of PE and DVT (PEP Trial Collaborative Group, 2000). Of the 2,047 patients assigned to
aspirin, 15 or .73% developed nonfatal DVT, eight or .39% developed non-fatal PE, and
one or .05% developed fatal PE (PEP Trial Collaborative Group, 2000). Of the 2,041
patients assigned to placebo, 19 or .93% developed nonfatal DVT, eight or .39%
developed non-fatal PE, and two or 1% developed fatal PE. The results of the PEP trial
demonstrated that aspirin decreases the risk of DVT and PE by at least one third (PEP
Trial Collaborative Group, 2000). The PEP study (2000) confirmed aspirin was an
effective means of chemical prophylaxis and could be used routinely for patients at high
risk of DVT/PE. The study supports that aspirin is effective in the prevention of VTE in
postoperative orthopedic patients and should be considered as a standard prophylactic
treatment. The agent was added to the organization’s electronic order set as standard VTE
prophylactic therapy for total hip replacement surgery.
The Antiplatelet Trialists’ Collaboration (ATC) is a worldwide three-part
overview of randomized trials of antiplatelet therapy. The authors used collaborative
meta analyses to compare antiplatelet regimens. Part I and II of the ATC proved that
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antiplatelet therapy, such as aspirin, reduces the risk of myocardial infarction, cerebral
infarction and other arterial occlusion (Antiplatelet Trialists’ Collaboration, 1994).
Part III of the ATC sought to determine the efficacy of antiplatelet therapy as
prophylaxis to prevent DVT or PE in surgical and high risk medical patients (Antiplatelet
Trialists’ Collaboration, 1994). Previously, aspirin had not been an accepted method of
treatment to prevent DVT or PE. The study included 53 trials with a total of 8,400
subjects who had an average of two weeks of antiplatelet therapy versus control in
general or orthopedic surgery (Antiplatelet Trialists’ Collaboration, 1994). Also included,
were nine trials with 600 patients of antiplatelet therapy versus control in other types of
immobility and 18 trials with 1,000 patients receiving one antiplatelet regimen over
another. For elective orthopedic surgery, 18 randomized trials with 1,154 patients were
identified (Antiplatelet Trialists’ Collaboration, 1994). Elective orthopedic surgery
patients that received aspirin therapy for two weeks observed a 49% reduction in DVT,
while a reduction in PE of 51% was noted (Antiplatelet Trialists’ Collaboration, 1994).
The ATC Part III (1994) substantiated that aspirin reduces both the incidence of DVT and
PE in elective orthopedic surgery patients, traumatic orthopedic surgery and patients
having general surgery. Bleeding complications were not consistently measured;
however, each collaboration suggested when using aspirin the risk of bleeding is small.
Aspirin has been shown to protect against DVT, PE, and other vascular events.
Additionally, aspirin is well known, accessible, and provides a low-cost option for
elective orthopedic surgery patients to prevent against VTE. The study supports that
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when aspirin is used for VTE prophylaxis in elective orthopedic surgery patients, it is
both effective in the prevention of VTE and does not increase the risk of bleeding
postoperatively. Based on the evidence of this important study, aspirin was added to the
electronic order set as standard VTE prophylaxis for total hip replacement surgery.
The purpose of the Antithrombotic Trialists’ Collaboration (2002) meta-analysis
review was to determine the effects of antiplatelet therapy in patients with high risk of
vascular occlusive events. A total of 287 studies were evaluated comprising 135,000
subjects to compare antiplatelet therapy versus control and 77,000 subjects in
comparisons of different antiplatelet regimes (Antithrombotic Trialists’ Collaboration,
2002). The results of the meta-analysis revealed that antiplatelet therapy protects against
vascular events among patients with unstable angina, intermittent claudication, and atrial
fibrillation (Antithrombotic Trialists’ Collaboration, 2002). Of the 287 studies, 32 trials
which examined PE found that antiplatelet therapy reduced the risk of fatal and nonfatal
PE by 25% among patients undergoing orthopedic surgery (Antithrombotic Trialists’
Collaboration, 2002). The study supports the efficacy of aspirin in reducing PE events for
patients having orthopedic surgery. The evidence further supports aspirin as standard
VTE prophylaxis in total hip replacement and was added to the electronic order set.
Efficacy of Enoxaparin to Decrease Venous Thromboembolism
Turpie et al. (1986) conducted a randomized controlled trial of a low-molecular
weight heparin, enoxaparin to prevent deep vein thrombosis in patients undergoing
elective hip surgery. Fifty subjects received enoxaparin and 50 received placebo.
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Prophylactic treatment was begun postoperatively in the 50 subjects who received
enoxaparin and the 50 who received placebo, and continued for 14 days. Thrombosis was
identified in 6 of 50 or 12% in the enoxaparin group and in 21 of 50 or 42% in the
placebo group. The results of the trial concluded that enoxaparin is an extremely effective
and safe form of VTE prophylaxis for elective hip arthroplasty patients (Turpie et al.,
1986). Randomized control trials provide the strongest empirical evidence of a
treatment’s efficacy, which affords physicians with the information to individualize
patient treatments in clinical practice. The study supports the efficacy of enoxaparin in
reducing VTE for patients having hip replacement surgery. Enoxaparin was added to the
electronic order set as standard prophylaxis for total hip replacement patients that are
identified to be at the highest risk of developing VTE.
In 1988, a randomized, double blind placebo controlled study, sought to compare
the efficacy and safety of enoxaparin and standard heparin for VTE prophylaxis after
elective hip surgery (Planes et al., 1988). A total of 237 subjects were randomized into
either active or control treatment. One hundred twenty-four subjects were randomly
assigned to the active treatment arm and received enoxaparin 40mg subcutaneously 12
hours prior to surgery and then daily for 14 days or until discharge from the hospital. One
hundred thirteen subjects were assigned to the control treatment arm and received
unfractionated heparin (UFH) 5,000 international units subcutaneously 2 hours before
surgery and then every 8 hours for 14 days or until discharge from the hospital. For those
receiving enoxaparin, deep vein thrombosis was identified in 15 of 120 or 12.5 % and 27
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of 108 or 25% for those receiving UFH (Planes et al., 1988). It was concluded that
treatment with daily enoxaparin significantly reduced the incidence of overall and
proximal DVT than those treated with UFH three times a day (Planes et al., 1988).
Randomized control trials provide the strongest empirical evidence of a treatments
efficacy and assist physicians to modify clinical practice to improve patient outcomes.
The study supports enoxaparin’s efficacy in reducing DVT without increasing the risk of
bleeding. The agent was added to the electronic order set for total hip replacement
patients identified at high risk of developing VTE.
Levine et al. (1991) completed a double-blind, randomized, control trial
comparing low molecular weight heparin (enoxaparin) with standard unfractionated
heparin. The goal of the study was to evaluate the efficacy and safety of enoxaparin
compared with heparin for the prevention of postoperative DVT in patients undergoing
total hip replacement surgery. Six hundred sixty-five patients were randomized and
received either enoxaparin 30 mg subcutaneously twice daily or standard heparin 7,500
units subcutaneously twice daily (Levine et al., 1991). The treatments were started 12 to
24 hours after surgery and continued for 14 days (Levine et al., 1991). Thrombosis
occurred in 17.1% of the subjects that received enoxaparin and 19% of those given
standard heparin (Levine et al., 1991). Bleeding complications occurred in 5.1% of
subjects that received enoxaparin and 9.3% of subjects that received heparin (Levine et
al., 1991). The study concluded that total hip replacement subjects who were
administered enoxaparin had a lower rate of thrombosis and significantly less bleeding
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than those that were administered heparin (Levine et. al., 1991). The study supports
enoxaparin as an effective and safe agent in DVT prophylaxis for total hip replacement.
Since the agent does not show evidence of increased bleeding complications it was
included in the organization’s electronic order set.
Bergqvist et al. (1996) conducted a prospective, randomized double-blind study
for subjects undergoing elective hip replacement to evaluate whether anticoagulation for
one month post-operatively with enoxaparin is more effective therapy than enoxaparin
given only during the acute hospitalization period. Two hundred sixty-two subjects
received prophylaxis against thrombosis with enoxaparin 40 mg subcutaneously daily
during their hospitalization (Bergqvist et al., 1996). The first dose of enoxaparin was
administered the evening prior to surgery. At discharge, subjects were randomly assigned
to receive either enoxaparin or placebo once daily for 21 days (Bergqvist et al., 1996).
The VTE incidence rate observed for the placebo group was 39% while the enoxaparin
group was 18% (Bergqvist et al., 1996). The study concluded that extending prophylaxis
with enoxaparin into the post-acute care setting significantly decreased VTE incidence in
total hip replacement surgery (Bergqvist et al., 1996). Based on the results of the study,
the organization’s VTE electronic order set recommends enoxaparin for at least 21 days
after hospital discharge for total hip replacement surgery.
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Efficacy of Intermittent Pneumatic Compression to Decrease Venous
Thromboembolism
Hull et al. (1990) completed a randomized trial to assess if calf and thigh
compression devices were effective in preventing VTE after total hip replacement when
compared with a control group that was given no prophylaxis. Thrombosis was identified
in 77 of 158 or 49% of the control subjects versus 36 of 152 or 24% of subjects given
intermittent compression (Hull et al., 1990). It was concluded that intermittent leg
compression significantly decreased the frequency of thrombosis after total hip
replacement surgery. Intermittent pneumatic compression devices were included in the
organization’s electronic order set as part of standard VTE prophylaxis therapy for all
patients following total hip replacement surgery.
A prospective study of 502 total hip arthroplasty subjects conducted by Hooker,
Lachiewicz, and Kelley (1999) sought to appraise the effectiveness of intermittent
pneumatic compression in the prevention of VTE after total hip arthroplasty. All subjects
had bilateral thigh-high anti-embolic stockings and intermittent pneumatic compression
devices applied at the start of the procedure and were maintained throughout the postoperative period except for personal hygiene or participating in physical therapy (Hooker,
Lachiewicz, & Kelley, 1999). Lower extremity ultrasound discovered that 23 of 502 or
4.6% of subjects developed an asymptomatic thrombosis, while 3 of 502 or .6%
developed a symptomatic pulmonary embolism confirmed with a lung scan (Hooker et
al., 1999). Hooker et al. (1999) reported 1% of subjects experienced minor bleeding
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complications. It was concluded that the lower prevalence of both DVT and PE with
intraoperative and postoperative intermittent pneumatic compression is comparable with
that associated to chemical prophylaxis (Hooker et al., 1999). A weakness of the study
was that it examined elastic compression stockings and intermittent pneumatic
compression as prophylaxis against VTE, which makes it difficult to determine if one
mechanical therapy is superior to another. The organization elected to add intermittent
pneumatic compression devices to their electronic order set as standard VTE prophylaxis
therapy following total hip replacement surgery.
Fujisawa, Naito, Asayama, Kambe, and Koga (2003) compared two different
types of intermittent pneumatic compression devices for the prevention of thrombosis and
leg swelling following total hip replacement surgery. Fifty-eight subjects were assigned
to the calf-thigh pneumatic compression group and 63 were assigned to the plantar
compression group (Fujisawa, Naito, Asayama, Kambe, & Koga, 2003). Seven days after
hip replacement surgery, the circumference of the thigh was measured for both groups.
The calf-thigh circumference ratio averaged 1.22% and the plantar averaged 3.19%
(Fujisawa et al., 2003). The study concluded that calf-thigh pneumatic compression is
more effective than plantar compression in decreasing swelling and is less likely to
contribute in causing thrombosis due to decreased vein flow (Fujisawa et al., 2003). The
organization and orthopedic surgeons agreed to add intermittent pneumatic compression
devices rather than plantar compression to the electronic order set.
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Ben-Galim et al. (2004) studied the efficacy of a battery operated and mobile
intermittent pneumatic compression device compared to a commonly used intermittent
compression device that was not portable. Twenty-five subjects were randomized into the
mobile compression device and the nonmobile compression device to compare the
efficacy of the device in preventing DVT after joint replacement surgery (Ben-Galim et
al., 2004). Both groups also received the routine treatment of heparin 5,000 units
subcutaneously twice a day for six days following surgery (Ben-Galim et al., 2004).
Doppler ultrasounds were performed on post-operative day 6 for all patients and there
were no reports of DVT or PE discovered in any of the 50 patients. The study concluded
that mobile compression devices were not superior to nonmobile compression devices
and both devices are effective in the prevention of VTE for patients after total joint
replacement surgery (Ben-Galim et al., 2004). The organization and orthopedic surgeons
decided that nonmobile intermittent pneumatic compression devices were appropriate for
the postoperative total hip VTE electronic order set.
General Review of Literature
Venous thromboembolism, a disease process that encompasses DVT and PE
(Baser, Sengupta, Dysinger, & Wang, 2012), is a serious medical condition affecting
approximately 350,000 – 900,000 Americans every year (Streiff et al., 2014). Deep vein
thrombosis are blood clots that occur in deep veins in the body, often the lower extremity
while PEs occur when a clot breaks loose and enters the arteries of the lungs (Office of
the Surgeon General (U.S.); National Heart, Lung, and Blood Institute (U.S.), 2008). Of
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the people who develop VTE, approximately 100,000 die due to sudden death, and 30% 50% with lower extremity DVT develop post thrombotic syndrome causing long term
swelling, pain, discoloration, and ulcers in the affected extremity (Streiff et al., 2014).
Furthermore, Streiff et al. (2014) report 10% -30% of people who survive the first
occurrence will develop another VTE within five years.
According to CMS, VTE is considered one of most preventable causes of death in
hospitalized patients (Centers for Medicare & Medicaid Services, 2014b). In 2012, CMS
added VTE to the hospital acquired conditions (HAC’s) reimbursement policies
(Kohlbrenner, Whitelaw, & Cannaday, 2011). “Medicare, Medicaid, and private health
plans alike are refusing to pay for complications that usually can be prevented by
adopting the CMS HAC and the National Quality Forum never-event policies”
(Kohlbrenner, Whitelaw, & Cannaday, 2011, p. 123). Hospital-acquired VTE care costs
approximately $58, 627 per case (Kohlbrenner, Whitelaw, & Cannaday, 2011).
Furthermore, Kohlbrunner, Whitelaw, and Cannaday (2011) reported in 2007 that health
care facilities HAC costs accounted for 12.2% of the total liability costs. The Centers for
Disease Control and Prevention (CDC) reported the United States spends $5to $8 billion
per year on direct medical costs associated with VTE (CDC, 2011). The cost of VTE is
expensive to the healthcare system and cannot be sustained.
Despite many efforts to increase awareness of VTE in hospitalized patients, it still
occurs. In the quest to reduce VTE, clinical information systems may provide support for
clinicians to deliver consistent and reliable quality patient care. Hardwiring clinical
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processes into electronic systems promotes safety and reduces the ability of staff to
ignore or work around necessary measures that could save someone’s life and reduce the
overall VTE cost to the healthcare system.
American Academy of Orthopedic Surgery (AAOS) Guidelines
The AAOS Preventing Venous Thromboembolic Disease in Patients Undergoing
Elective Hip and Knee Arthroplasty Evidence-Based Guideline and Evidence Report
(2011b) established clinical practice guidelines based on a systematic review of published
studies on preventing venous thromboembolic disease in patients undergoing elective hip
and knee arthroplasty. The AAOS report (2011b) provides a summary of the evidence
rating methodology and description of the evidence strength to assist provider’s decision
making in the prevention of VTE. The evidence ratings have been classified by the
AAOS as strong, moderate, limited, inconclusive, and consensus. The following table
provides a summary of the clinical practice guideline evidence rating recommendations
on preventing VTE for elective hip and knee arthroplasty patients.
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Table 1
Recommendation Strengths, Descriptions and Clinical Implications According to the
AAOS
Evidence
Rating
Strong

Moderate

Limited

Inconclusive

Description of Evidence Strength
Evidence is based on two or more “High” strength
studies with consistent findings in support of
recommending for or against the intervention.
A Strong (positive) recommendation means that
the benefits of the recommended approach clearly
exceed the potential harm, and/or that the strength
of the supporting evidence is high.
A Strong (negative) recommendation means that
the quality of the supporting evidence is high. A
harms analysis on this recommendation was not
performed.
Evidence from two or more “Moderate” strength
studies with consistent results, or evidence from a
single “High” strength study recommending for or
against the intervention.
A Moderate recommendation means that the
benefits exceed the potential harm (or that the
potential harm exceeds the benefits in the case of a
negative recommendation), but the
quality/applicability of the supporting evidence is
not as strong.
Evidence from two or more “Low” strength
studies with consistent results, or evidence from a
single Moderate strength study recommending for
or against the intervention.
A Limited recommendation means that the
strength of the supporting evidence is
unconvincing, or that well-conducted studies show
little clear advantage to one approach over
another.
Evidence from a single low strength study or
otherwise conflicting evidence that does not allow
a recommendation to be made for or against the
intervention.
An Inconclusive recommendation means that
there is a lack of compelling evidence that has
resulted in an unclear balance between benefits
and potential harm.

Implication for Practice
Practitioners should follow a
Strong recommendation unless a
clear and compelling rationale for
an alternative approach is present.

Practitioners should generally
follow a Moderate
recommendation but remain alert
to new information and be
sensitive to patient preferences.

Practitioners should exercise
clinical judgment when following
a recommendation classified as
Limited, and should be alert to
emerging evidence that might
negate the current findings.
Patient preference should have a
substantial influencing role.
Practitioners should feel little
constraint in following a
recommendation labeled as
Inconclusive, exercise clinical
judgment, and be alert for
emerging evidence that clarifies
or helps to determine the balance
between benefits and potential
harm.
table continues
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Evidence
Rating
Consensus

Description of Evidence

Implication for Practice

The supporting evidence is lacking and requires
the work group to make a recommendation based
on expert opinion by considering the known
potential harm and benefits associated with the
treatment.

Patient preference should have a
substantial influencing role.
Practitioners should be flexible in
deciding whether to follow a
recommendation classified as
Consensus, although they may
give it preference over
alternatives. Patient preference
should have a substantial role.

A Consensus recommendation means that expert
opinion supports the guideline recommendation
even though there is no available empirical
evidence that meets the inclusion criteria for
systematic review.

Note. From “Preventing Venous Thromboembolic Disease in Patients Undergoing
Elective Hip and Knee Arthroplasty,” by American Academy of Orthopedic Surgeons,
2011, Evidence-Based Guideline and Evidence Report, p. 36.
Within the AAOS report (2011b), recommendations of VTE management for
pharmacological and mechanical prophylaxis discuss the three essentials. They are the
use of pharmacological and mechanical prophylactic agents, the type of prophylactic
strategy, and the duration of prophylaxis. The fifth recommendation of the AAOS report
suggests the use of pharmacological agents and/or mechanical compression devices for
the prevention of VTE disease in patients undergoing elective hip or knee arthroplasty,
and who are not at elevated risk beyond that of surgery itself for VTE or bleeding. The
grade of recommendation is moderate, which means that the benefits exceed the potential
harm, but the strength of the supporting evidence is not as strong. The AAOS performed
a network meta-analysis to assess which pharmacological prophylactic agent may be the
most effective (AAOS, 2011b). The results of the analysis did not suggest that one type
of pharmacological prophylaxis is superior over another. The AAOS (2011b) report
further indicates that the current evidence is unclear about which prophylactic strategy is
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optimal or suboptimal and is unable to provide recommendations for or against specific
prophylactics in these patients. The grade of recommendation is inconclusive, which
means there is lack of compelling evidence resulting in an unclear balance between
benefits and potential harm (AAOS, 2011b). Table 1 provides a description of the
evidence rating and implications of practice for an inconclusive recommendation.
In the absence of reliable evidence about how long to employ these prophylactic
strategies, it is the opinion of the work group that patients and physicians discuss the
duration of prophylaxis (AAOS, 2011b). The grade of recommendation is consensus,
which, means that expert opinion supports the guideline recommendation even though
there is no available empirical evidence that meets the inclusion criteria of the guideline’s
systematic review (AAOS, 2011b). Given the broad nature of the recommendations, the
organization and orthopedic surgeons determined that there was important evidence to
include aspirin, enoxaparin, and IPCDs in the electronic order set.
American College of Chest Physicians (ACCP) Guidelines
In 2012, the ACCP published Antithrombotic Therapy and Prevention of
Thrombosis, 9th edition: CHEST Evidence-Based Clinical Practice Guidelines. The
ACCP guidelines include the division of prevention into three major areas: medical
patients, orthopedic surgery patients, and other surgical patients (Falck-Ytter et al.,
2012). For this project, the ACCP guidelines that focus on optimal prophylaxis to reduce
postoperative VTE in orthopedic surgery patients will be discussed. Criteria suggested by
the Grading of Recommendations Assessment, Development and Evaluation (GRADE)
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working group were used to evaluate quality of evidence. Randomized control trials start
as high-quality evidence and observational studies as low-quality evidence (Agency for
Healthcare Research & Quality [AHRQ], 2014b).
According to AHRQ (2014b) other factors that affect the rating of quality include
the risk of bias; precision; consistency; directness of results; likelihood of publication
bias; and presence of very large effects. The ACCP modification of the GRADE system
differs only in that the quality of a body of evidence can be high (A), moderate (B), or
low (C) (AHRQ, 2014b). “The formulation of recommendations considered the balance
between the desirable and undesirable consequences of an intervention; the quality of the
evidence; the variability in patient values and preferences; and, on occasion, resource use
issues” (AHRQ, 2014b, para. 37).
When desirable effects were much greater than undesirable effects, the
recommendations were graded as strong. Strong recommendations were labeled 1 and
worded as “The expert panel recommends” (AHRQ, 2014b). “Recommendations were
graded as weak when desirable effects were not clearly greater or less great than
undesirable effects” (AHRQ, 2014b, para. 37). Weak recommendations were labeled as 2
and worded as “The expert panel suggests” (AHRQ, 2014b). The rating of the quality of
evidence- high, A; moderate, B; or low, C is provided with the strength of each
recommendation (AHRQ, 2014b). Table 2 provides a summary of the ACCP rating
scheme for the strength of the recommendations on the prevention of VTE in orthopedic
surgery patients.
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Table 2
Strength of the Recommendations Grading System According to the ACCP
Grade of
Recommendation*
Strong
recommendation, highquality evidence,
Grade 1A

Benefit vs.
Risk and
Burdens
Benefits
clearly
outweigh
risk and
burdens or
vice versa.

Methodologic Quality of
Supporting Evidence

Implications
Recommendation can apply to
most patients in most
circumstances. Further research is
very unlikely to change
confidence in the estimate of
effect.

Strong
recommendation,
moderate-quality
evidence,
Grade 1B

Benefits
clearly
outweigh
risk and
burdens or
vice versa.

Strong
recommendation, lowor very-low-quality
evidence,
Grade 1C

Benefits
clearly
outweigh
risk and
burdens or
vice versa.

Consistent evidence from
randomized controlled
trials (RCTs) without
important limitations or
exceptionally strong
evidence from
observational studies.
Evidence from RCTs with
important limitations
(inconsistent results,
methodologic flaws,
indirect or imprecise), or
very strong evidence from
observational studies.
Evidence for at least one
critical outcome from
observational studies, case
series, or from RCTs with
serious flaws or indirect
evidence.

Weak
recommendation, highquality evidence,
Grade 2A

Benefits
closely
balanced
with risks
and burden.

Consistent evidence from
RCTs without important
limitations or exceptionally
strong evidence from
observational studies.

Weak
recommendation,
moderate-quality
evidence,
Grade 2B

Benefits
closely
balanced
with risks
and burden.

Evidence from RCTs with
important limitations
(inconsistent results,
methodologic flaws,
indirect or imprecise) or
very strong evidence from
observational studies

Recommendation can apply to
most patients in most
circumstances. Higher quality
research may well have an
important impact on confidence in
the estimate of effect and may
change the estimate.
Recommendation can apply to
most patients in many
circumstances. Higher-quality
research is likely to have an
important impact on confidence in
the estimate of effect and may
well change the estimate.
The best action may differ
depending on circumstances or
patient or society values. Further
research is very unlikely to
change confidence in the estimate
of effect.
Best action may differ depending
on circumstances or patient or
society values. Higher-quality
research may well have an
important impact on confidence in
the estimate of effect and may
change the estimate.
table continues
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Grade of
Recommendation*
Weak
recommendation, lowor very-low-quality
evidence,
Grade 2C

Benefit vs. Risk
and Burdens
Uncertainty in the
estimates of benefits,
risks, and burden;
benefits, risk, and
burden may be
closely balanced.

Methodologic Quality
of Supporting Evidence
Evidence for at least one
critical outcome from
observational studies,
case series, or RCTs,
with serious flaws or
indirect evidence

Implications
Other alternatives may be
equally reasonable. Higherquality research is likely to
have an important impact on
confidence in the estimate of
effect and may well change
the estimate.

Note. From “Prevention of VTE in Orthopedic Surgery Patients: Antithrombotic Therapy
and Prevention of Thrombosis, 9th ed: Evidence-Based Clinical Practice Guidelines,” by
American College of Chest Physicians, 2012, AHRQ National Guideline Clearinghouse,
para. 42.
The ACCP Guidelines for Prevention of VTE in Orthopedic Surgery Patients
(2012) are more prescriptive in their recommendations for pharmacological and
mechanical prophylaxis than the AAOS 2011 VTE Prevention Guidelines. In patients
undergoing total hip or total knee arthroplasty, the ACCP (2012) recommends the use of
low-molecular weight heparin such as enoxaparin and aspirin (Grade 1B) or an
intermittent pneumatic compression device (IPCD Grade 1C). Low molecular-weight
heparin such as enoxaparin is recommended and preferred to other pharmacological
agents (Grade 2B/2C). During the hospital stay, IPCD’s are recommended in addition to
pharmacological prophylaxis (Grade 2C Falck-Ytter, et al., 2012). Pharmacological
prophylaxis should be extended for up to 35 days after discharge from the hospital (Grade
2B Falck-Ytter, et al., 2012). Intermittent pneumatic compression devices or no
prophylaxis is suggested for patients with increased bleeding risk (Falck-Ytter, et al.,
2012).
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Upon review of the ACCP 2012 VTE recommendations specific to orthopedic
surgery patients, the organization and orthopedic surgeons were able to finalize how each
prophylactic agent would be used following surgery. Aspirin was recommended for
patients classified at routine risk, while enoxaparin was recommended for patients
classified at high risk of developing VTE. IPCDs would be applied to all patients
postoperatively before leaving the operating room. The organization and orthopedic
surgeons reached consensus to include aspirin, enoxaparin, and IPCD orders in the
postoperative electronic VTE order set.
Technology/CPOE
The landmark report To Err is Human published in 1999 by the Institute of
Medicine (IOM), has prompted hospitals to closely examine care delivery models and
implement strategies to reduce medical errors and improve patient safety. The IOM
reported that preventable adverse events are a leading cause of death in United States
hospitals, accounting for between 44,000 – 98,000 lives lost yearly due to medical errors
(Kohn, Corrigan, & Donaldson, 2000). Furthermore, medication errors are cited as one of
the most common errors in hospitals (Kohn, Corrigan, & Donaldson, 2000). One of the
key strategies identified to improve medication safety is computerized provider order
entry (CPOE). Electronic order entry benefits include not having to decipher illegible
handwriting, clinical checking decisions made by providers at the beginning of the
medication cycle, and decreased turnaround time from order placement to actual
medication administration
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It is no secret to healthcare that hospitals have been slow to adopt health
information technology (HIT), specifically electronic health records (EHRs). One of the
major factors of slow adoption of this technology is related to the cost of implementation
and maintenance of the system while trying to maintain a positive financial performance
(Encinosa & Bae, 2013). In the State of the Union Address in 2004, President Bush
presented a HIT plan offering Americans EHRs within 10 years that would improve
quality, decrease cost, and reduce preventable errors (The White House, 2004). In 2009
to stimulate the economy, President Obama proposed and signed a bill passing the
American Recovery and Reinvestment Act (ARRA). Part of the ARRA initiative is to
modernize healthcare by offering financial incentives to hospitals if they are using a
certified EHR in a meaningful way as defined in the different stages of Meaningful Use
(MU) criteria (The White House, 2009).
The patient safety organization Leapfrog (2015) recommends the use of
computerized provider order entry (CPOE) to integrate guidance for the physician into
the flow of patient care, via standard order sets. As part of a patient safety quality
improvement initiative, organizations such as Johns Hopkins have developed
multidisciplinary VTE prevention teams using technology to design evidence-based
strategies to prevent VTE (Streiff et al., 2014). The Johns Hopkins team determined that
paper-based order sets were difficult to use and developed computer-based VTE smart
order sets (Streiff et al, 2014). The VTE smart order sets were inserted into all admission
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and transfer order sets for all medical and surgical patients. Streiff et al. (2014) reported
VTE prophylaxis increased to 85% with the addition of smart order sets.
Maynard and Stein (2010) also recommend embedding electronic VTE order sets
into admission, transfer, and perioperative electronic order sets. The implementation of
HIT, such as smart order sets can lead to efficient clinician workflow and improved
quality patient outcomes. Providing appropriate protocol guidance within the electronic
order set that enables efficient clinical decision making may lead to a reduction in
orthopedic VTE outcomes.
Conceptual Framework
An appropriate model to explore the problem of VTE in the postoperative
orthopedic THA patient population was the Accountable Care Organization (ACO)
model. The triple aims of the ACO model underscores reducing cost, improving quality,
and enhancing patient experience (McClellan, McKethan, Lewis, Roski, & Fisher, 2010).
Accountable Care Organizations are groups of doctors, hospitals, and other health care
providers, who come together to provide more coordinated, high quality care to Medicare
patients at lower cost (McClellan et al., 2010).
A core principle of the ACO model is the implementation of a robust quality
measurement strategy (McClellan et al., 2010). According to the AAOS (2011a), “The
ACO model is the first attempt to link quality and patient experience to financial rewards
when providers meet quality and cost containment benchmarks” (p. 8). Furthermore,
AAOS (2011a) recommends the need for technology platforms and systems that will
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enable data gathering, data integration, and public reporting of quality and cost outcomes
will be required for ACOs to be successful. Developing a robust quality measurement
strategy specifically related to VTE in the orthopedic population may instill public
confidence that cost savings are directly linked to evidence-based nursing practice and
care improvements.
An essential goal of an ACO is to ensure patients receive coordinated care at the
right time while avoiding duplicative services and medical errors. As an ACO begins to
deliver high quality care at less cost, the ACO can share in the savings realized in the
Medicare program (CMS, 2015a). ACO models offer nurses the opportunity to act as care
coordinators, communicators, quality improvement managers, and providers of advanced
levels of care (Nursing Alliance for Quality Care, n.d.). Within the care coordinator
model, nurse case managers have the opportunity the implement an evidence-based
screening tool to identify orthopedic patients at increased risk for VTE and develop a
plan of care to manage this risk prior to hospital admission, during the acute
hospitalization, and the postacute care phase. Well-coordinated early identification and
intervention by nurses may result in improved outcomes and overall VTE management
for the postoperative orthopedic population.
Summary
Venous thromboembolism remains an important and serious complication for
patients undergoing joint replacement surgery. Even though there are practice guidelines
from the AAOS and ACCP on the prevention of VTE for orthopedic patients, the
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guidelines are cumbersome, very lengthy and not aligned. Lack of consistent
recommendations can cause confusion for providers over which pharmacological agent is
most effective in preventing postoperative thrombosis. Practice guidelines support that a
multimodal approach is necessary to decrease the risk of developing VTE. After review
of the literature, the organization’s orthopedic surgeons agreed to standardize VTE
prophylaxis in the electronic order set. Aspirin was the agent of choice for patients at
standard risk and enoxaparin was the agent of choice for patients at higher risk of
developing VTE after hip replacement surgery. Intermittent pneumatic compression
devices were also part of standard VTE prophylaxis therapy and were to be ordered for
all postoperative hip replacement patients. Implementation of the evidence-based
electronic order set increased the provider’s adherence to ordering standard prophylactic
treatment and decreased VTE orthopedic outcomes. The next section will discuss the
project design and methods.
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Section 3: Methodology
Introduction
Kettner, Moroney and Martin (2013) stated “the purpose of the program design
phase is to put together that service or combination of services that appears to have the
best possible chance of achieving the program’s objectives” (p. 19). Obtaining input from
key stakeholders on the design of this program was critical to its success. The hospital
organization study site had been an outlier in orthopedic VTE outcomes with
performance in the bottom 10th percentile nationally. The purpose of this project was to
assess the difference of orthopedic VTE occurrences in the postoperative THA patient
before and after implementation of the electronic VTE order set. There were two
objectives for the project (a) to evaluate if technology influences the adherence to
ordering of mechanical prophylaxis in the THA patient (b) to evaluate if technology
influences the adherence to ordering pharmacological prophylaxis in the THA patient. In
this section, I will discuss the project design, population and sampling, data collection,
data collection tool, protection of human subjects, data analysis, and project evaluation
plan.
Project Design and/or Methods
All primary total hip arthroplasty cases between the preelectronic order set
implementation period of January 1, 2014-June 30, 2014 and the postelectronic order set
implementation period of January 1, 2015-June 30, 2015 was provided by Stryker.
Stryker is a contracted vendor that specializes in collecting and extracting important
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hospital metrics into an outcomes dashboard. Stryker provided the hip arthroplasty cases
to the hospital organization’s chief medical information office (CMIO). The CMIO
obtained information from the embedded analytics clinical information system. I
calculated a comparison of the percent of adherence to pharmacological and mechanical
prophylaxis before and after implementation of the electronic order set to evaluate if
technology was affecting consistent ordering of prophylaxis treatment. The VTE
occurrence rate was reported before and after implementation of the electronic order set.
Stryker provided VTE occurrences for the pre- and postelectronic order set
implementation period to assess if technology was positively or negatively impacting
VTE outcomes.
Population and Sampling
I collected the target data from discharged patients that underwent a primary THA
between January 1, 2014-June 30, 2014 and January 1, 2015-June 30, 2015. The project’s
inclusion criterion was that the patient underwent a primary total hip replacement
procedure. Hip revision and hip fracture procedures were excluded from the project.
Total hip replacement patients had a diagnosis of osteoarthritis or degenerative joint
disease and had to meet the criteria for medical necessity. The participants ranged in age
from 40 to 90 and included all types of insurance. The THA payer mix consisted of 40%
commercial, 30% managed Medicare, 25% Medicare, 2% Medicaid, and 3% other.
Approximately 400 THA procedures are performed within a 6-month period at the
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facility. I included the electronic medical record for every patient who underwent a
primary THA during the two defined time periods above.
Data Collection
The data provided by Stryker contained every primary THA procedure performed
between January 1, 2014-June 30, 2014 and January 1, 2015-June 30, 2015. The data
parameters comprised the participants’ account number, admission date, discharge date,
procedure type, VTE complications during admission, and readmissions within 30 days
of discharge for VTE. The procedure data were delivered to the CMIO via an encrypted
Excel file that required a password to access. The CMIO used patient account numbers
provided by Stryker to query the embedded analytics database from the hospital
organization’s clinical information system. The CMIO used structured query language to
pull cases in which VTE prophylaxis, mechanical, and/or pharmacological prophylaxis
was ordered. The data were then compiled in an Excel spread sheet and sent to me. All
participants were completely deidentified and assigned a patient number by the CMIO.
From there, I analyzed the differences in ordering VTE prophylaxis, mechanical and
pharmacological prophylaxis, and VTE outcomes before and after the implementation of
the electronic order set.
Instruments
Data collection tool. I developed one of the data collection tools in Excel for the
project (Appendix A) myself. The tool contained headings to capture the variables
participant numbers assigned, admit date, discharge date, procedure type, VTE
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complication during admission, VTE readmit within 30 days, VTE prophylaxis ordered,
mechanical prophylaxis ordered, and pharmacological prophylaxis ordered. I developed
the tool to have VTE complication during admission, VTE readmit within 30 days, and
prophylaxis ordering have a corresponding yes or no entered to examine the difference in
the percentages of ordering of the order set and the VTE outcomes before and after
implementation of the electronic order set.
Protection of Human Subjects
I obtained approval from hospital administration, the chief medical officer, the
chief of orthopedic surgery, and Walden University’s Institutional Review Board (IRB)
prior to beginning the project. The IRB approval number for this study is 03-30-170183526. I also completed The National Institutes of Health web-based training course
“Protecting Human Research Participants” on February 16, 2014 (Certification Number
1404756). The key stakeholders were made aware of the purposes of the project and were
given the opportunity to ask questions. I stored data collected for the project in a secure,
encrypted, password protected file located on my computer hard drive. The computer was
kept in a locked office that was accessible only to me. To comply with Health Insurance
Portability and Accountability Act, all patient specific information was deidentified. In
accordance with the organizational policy, protection of patient information was
maintained at all times.
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Data Analysis
I used descriptive statistics to analyze the data collected from the project.
Descriptive statistics are numbers that are used to summarize and describe data (Grove,
Burns, & Gray, 2013). The differences in the ordering of VTE prophylaxis, mechanical
and pharmacological prophylaxis, and VTE outcomes both before and after
implementation of the order set were analyzed and compared. The differences between
the pre-and postorder set implementation results were displayed as a percentage change.
There were four project questions. The first project question was: What is the
difference in the ordering of VTE prophylaxis before and after implementation of the
electronic order set? I used descriptive statistics to determine and compare the percentage
of orders for VTE prophylaxis and the percentage of orders with no VTE prophylaxis.
The results were completed both before and after implementation of the electronic order
set. A comparison of the change in percentage of VTE ordering adherence both before
and after implementation of the order set were examined to determine if the order set
promoted ordering adherence.
The second question was: What is the difference in the ordering of mechanical
prophylaxis before and after implementation of the electronic order set? I used descriptive
statistics to determine and compare the percentage of orders for mechanical prophylaxis
only and the percentage of orders with no mechanical prophylaxis. A comparison of the
change in percentage of mechanical prophylaxis ordering adherence both before and after
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implementation of the electronic order set were examined to determine if the order set
promoted mechanical prophylaxis ordering adherence.
The third question was: What is the difference in the ordering of pharmacological
prophylaxis before and after implementation of the electronic order set? I used descriptive
statistics to determine and compare the percentage of orders for pharmacological
prophylaxis only and the percentage of orders with no pharmacological prophylaxis. A
comparison of the change in percentage of pharmacological prophylaxis ordering
adherence both before and after implementation of the electronic order set were examined
to determine if the order set promotes pharmacological prophylaxis ordering adherence. I
also completed another analysis with descriptive statistics to assess the percentage of
orders for both mechanical and pharmacological prophylaxis ordering adherence before
and after implementation of the electronic order set. This analysis indicated whether
implementation of the order set resulted in VTE prophylaxis ordering for both agents.
The fourth question was: What is the difference in orthopedic VTE occurrences
before and after implementation of the electronic order set? I calculated the percentage of
participants that developed VTE either during hospital admission or were readmitted
within 30 days of discharge with VTE using descriptive statistics to determine the
percentage of VTE outcomes. A comparison of VTE outcomes both before and after
implementation of the order set were completed to evaluate if technology influenced VTE
ordering adherence and reduced VTE occurrences in THA patients.
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Project Evaluation Plan
The plan-do-check-act (PDCA) or Deming cycle was an appropriate model to
evaluate the project. The PDCA cycle is a sequence of steps to obtain valuable learning
and knowledge for continuous improvement of a process or system (Taylor et al, 2014).
The PDCA cycle is used within the hospital organization to continuously and objectively
measure, monitor, evaluate, identify, and pursue opportunities to improve the outcomes
of patient care, service delivery and minimize the chances of adverse outcomes and
events. The organization’s quality department has been using this model of evaluation for
over 25 years because the steps are easy to follow and it represents a continual process to
explore improvement. The PDCA model provided an opportunity for me to evaluate
whether a standardized electronic VTE order set improved or worsened the adherence to
ordering mechanical and pharmacological prophylaxis and orthopedic VTE outcomes.
Analyzing the test of change informed me that sustainable improvement was possible and
the process did not require modification. Figure 1 provides a visual representation of the
PDCA Deming quality improvement cycle.
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Figure 1. Illustration showing Deming’s cycle plan do check act. From “Systematic
Review of the Application of the Plan-Do-Study-Act Method to Improve Quality in
Healthcare,” by Taylor, McNichols, Nicolay, Daizi, Bell, and Reed, 2014, BMJ Quality
and Safety 23(4), p. 292. Reprinted with permission.
Summary
In this project, I explored if technology influenced the adherence to ordering
mechanical and pharmacological prophylaxis in the postoperative THA patient. I
conducted an analysis using descriptive statistics to gather data on the adherence to
ordering prophylaxis and VTE outcomes. The data were analyzed to determine the
difference in ordering VTE prophylaxis after the order was implemented. A plan for the
protection of human subjects was maintained throughout the project. The PDCA model
was used to evaluate the project plan and the difference of orthopedic VTE occurrences
before and after implementation of the electronic order set. The next section will discuss
the findings and implications from the project.
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Section 4: Findings, Discussion, and Implications
Introduction
The purpose of the DNP project was to assess the difference of orthopedic VTE
occurrences in the postoperative THA patient before and after the implementation of the
electronic VTE order set. The ACSNSQIP 2014 Semiannual Report for the period of
January 2014 - March 2015 reported 10 VTE events in 546 orthopedic cases at the study
site. Based on the orthopedic VTE outcomes data, the hospital organization study site has
been classed as an outlier performing in the bottom 10th percentile when compared to
other organizations. I conducted this quality improvement project initiative at a regional
tertiary care facility comprised of 450 acute care beds. The organization has a large total
joint replacement program with almost 3,000 arthroplasty surgeries performed annually.
THA cases and VTE complications were provided for this project by Stryker for
the preelectronic order set period of January 1, 2014-June 30, 2014 and the postelectronic
order set implementation period of January 1, 2015-June 30, 2015. Using the THA cases
from Stryker, the hospital organization’s CMIO queried the EHRs to determine if VTE
prophylaxis and mechanical and pharmacological prophylaxis ordering adherence was
followed before and after implementation of the electronic order set. The data were
compiled in an Excel spreadsheet and sent to me for analysis. I analyzed the differences
in ordering of VTE prophylaxis, mechanical and pharmacological prophylaxis, and VTE
outcomes both before and after implementation of the order set and compared as a
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percentage of change. In this section, I will discuss the project findings, practice
implications, project outcomes, and project strengths and limitations.
Summary and Evaluation of Findings
With this DNP project, I aimed to evaluate the difference of orthopedic VTE
occurrences in the postoperative THA patient before and after the implementation of the
electronic order set. I had two objectives for this DNP project (a) to evaluate if
technology influenced the adherence to ordering mechanical prophylaxis in the THA
patient and (b) to evaluate if technology influenced the adherence to ordering
pharmacological prophylaxis in the THA patient.
Given the objectives of the project, I developed the following four questions to
guide the study:
1. “What is the difference in the ordering of VTE prophylaxis before and after
implementation of the electronic order set”?
2. “What is the difference in ordering of mechanical prophylaxis before and after
implementation of the electronic order set”?
3. “What is the difference in the ordering of pharmacological prophylaxis before
and after implementation of the electronic order set”?
4. “What is the difference in orthopedic VTE occurrences before and after
implementation of the electronic order set”?
In the following subsections, I will discuss the findings that resulted from my analysis.
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Project Question 1
There were a total of 325 primary THA participants included in the preelectronic
order set group for January 1, 2014-June 30, 2014 time period. Of the participants, 120 or
36.9% were men and 205 or 63.1% were women. The average age of men and women
were 64 and 67 years, respectively. VTE prophylaxis was ordered for 281 of 325 or
86.5% of the participants. Forty-four of 325 or 13.5% of the participants did not have
VTE prophylaxis orders consistent with either aspirin or enoxaparin.
There were a total of 406 primary THA participants included in the postelectronic
order set group for January 1, 2015-June 30, 2015 time period. Of the participants, 186 or
46% were men and 220 or 54% were women. The average age of men and women were
62 and 67 years, respectively. VTE prophylaxis was ordered for 362 of 406 or 89.2% of
the participants. Forty-four of 406 or 10.8% of the participants did not have VTE
prophylaxis orders consistent with either aspirin or enoxaparin.
Prior to the electronic order set implementation, the ordering of VTE prophylaxis
was 86.5%. The postelectronic ordering of VTE prophylaxis increased to 89.2%. The
difference between the pre- and postelectronic order set represents an increase of 2.7%.
Project Question 2
Three hundred and twenty-five of 325 or 100% of primary THA participants had
orders for mechanical prophylaxis with IPCDs prior to the electronic order set
implementation. Four hundred and six of 406 or 100% of primary THA participants had
orders for mechanical prophylaxis with IPCDs after the electronic order set was
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implemented. Ordering adherence for mechanical prophylaxis with IPCDs has remained
consistent with performance at 100%.
Project Question 3
Prior to the implementation of the electronic order set, 281 of 325 or 86.5% of
primary THA participants had pharmacological VTE prophylaxis orders. Two hundred
and eight of 325 or 64% of participants had aspirin orders and 73 of 325 or 22% had
orders for enoxaparin. Forty-four of 325 or 13.5% of participants had orders for other
pharmacological agents such as warfarin, dabigatran, and apixaban. These agents are not
considered part of the agreed upon VTE prophylactic protocol by the orthopedic
surgeons, and I placed them in the nonadherent category.
After the electronic order set implementation, 362 of 406 or 89.2% of primary
THA participants had pharmacological VTE prophylaxis orders. Two hundred and
seventy-seven of 406 or 68% of the participants had aspirin orders and 85 of 406 or
20.9% had orders for enoxaparin. Forty-four of 406 or 10.8% of participants had orders
for warfarin, dabigatran, rivaroxaban, and apixaban. These agents are not considered part
of the agreed upon VTE prophylactic protocol by the orthopedic surgeons and were not
included in the standardized electronic order set. I placed the ordering of these agents in
the nonadherent category.
For the preelectronic order set period, pharmacological VTE prophylaxis ordering
adherence was 86.5%, compared to the postelectronic order set period, which was 89.2%.
The difference observed between the two periods represents an increase of 2.7% in the
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ordering of pharmacological prophylaxis. The percentage of nonadherence to ordering
VTE pharmacological prophylaxis was 13.5% in the preelectronic order set period
compared to 10.8% in the postelectronic order set period. The difference observed
between the two periods is a reduction of 2.7%. The percentage of orders for both
mechanical and pharmacological prophylaxis ordering adherence prior to the electronic
order set was 281 of 325 or 86.5%, compared to the postelectronic order set period, which
was 362 of 406 or 89.2%. The difference observed between the two periods represents an
increase of 2.7% in the ordering of both mechanical and pharmacological prophylaxis.
The increase is attributed to the ordering of pharmacological agents because the ordering
of mechanical prophylaxis was 100%, both before and after implementation of the
electronic order set.
Project Question 4
Before implementation of the electronic order set, 10 of 325 or 3.08% of primary
THA participants developed a postoperative VTE. Two of 325 or .62% of VTEs occurred
during hospital admission and 8 of 325 or 2.46% were readmitted within 30 days of
hospital discharge. After implementation of the electronic order set, 3 of 406 or .74% of
primary THA participants developed a postoperative VTE. One of 406 or .25% of VTEs
occurred during hospital admission and 2 or .49% was readmitted within 30 days of
hospital discharge.
For the preelectronic order set period, 3.08% of participants developed a VTE as
compared to .74% for the postelectronic order set period. The difference I observed
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between the two-time periods represents a decrease in VTE outcomes of 2.34%. For the
preelectronic order set period, 2 of 325 or .62% of participants developed VTE during the
postoperative hospital admission as compared to 1 of 406 or .25% for the postelectronic
order set period. The difference observed represents a decrease of postoperative hospital
admission VTE by .37%. For the preelectronic order set period, 8 of 325 or 2.46% of
participants developed VTE within 30 days of hospital discharge as compared to 2 of 406
or .49% for the postelectronic order set period. The difference observed represents a
decrease in the VTE 30-day readmission rate by 1.97%.
Discussion of Findings in the Context of the Literature
I had two objectives for this quality improvement initiative. My first objective was
to evaluate if technology influenced the adherence to ordering of mechanical VTE
prophylaxis in the THA patient. The findings revealed that mechanical prophylaxis was
ordered 100% of the time both before and after implementation of the electronic order set.
The results suggested that technology did not have a negative impact on mechanical
prophylaxis ordering adherence, and performance of 100% was sustained with electronic
order entry. While paper-based order sets were difficult for providers to use, the practice
of ordering mechanical prophylaxis was hardwired into provider practice. With the
practice change of electronic order entry, the ordering of mechanical prophylaxis was
easily adopted and transferred with electronic order entry.
According to Cooley, May, Alwan and Sue (2012), studies have shown that when
end users are involved in the design of order set content there is a greater likelihood of
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successful CPOE implementation. Orthopedic subject matter experts were heavily
involved in the content development and format of the electronic order set. Their
involvement may have contributed to sustaining exemplary results with new technology
rather than observing a decline in ordering adherence. Developing standard VTE order
sets and protocols assures the patient receives the agreed upon standard (Maynard &
Stein, 2010). By standardizing with electronic order sets, the need to remember all
aspects of care for the clinician is reduced.
My second objective was to evaluate if technology influenced the adherence to
ordering pharmacological VTE prophylaxis in the THA patient. The findings revealed
that there was an increase of 2.7% in ordering the pharmacological prophylaxis protocol
from 86.5% to 89.2%. Nonadherence to ordering the pharmacological prophylaxis
protocol decreased by 2.7% from 13.5% to 10.8%. Based on these findings, the electronic
order set has positively influenced pharmacological ordering adherence and decreased
ordering outside of the protocol. Patients are more likely to be prescribed VTE
prophylaxis with a standardized order set (O’Connor, Adhikari, DeCaire, & Friedrich,
2009).
The pre- and postelectronic order set time periods that I analyzed demonstrated
that orthopedic VTE outcomes decreased by 2.34% from 10 to three occurrences in the
postoperative THA patient. When integrated with technology, standardized care processes
provide for more reliable consistent care delivery and better patient outcomes
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(McCartney, 2014). Well-designed evidence-based order sets can transform clinical
processes and clinician behavior.
The conceptual framework that I used for the DNP quality improvement project
was the Accountable Care Organization (ACO) model. The triple aims of the ACO model
underscores reducing cost, improving quality, and enhancing patient experience
(McClellan, McKethan, Lewis, Roski, & Fisher, 2010). A core principle of the ACO
model is the implementation of a robust quality measurement strategy (McClellan et al.,
2010). The model supported the work of the project by leveraging technology to query
the clinical information system to evaluate VTE prophylaxis ordering adherence and
orthopedic VTE outcomes. Prophylaxis ordering adherence information and misses can
be shared with providers in a timely manner to improve quality care, prevent VTE
outcomes, and improve patient experience.
Implications
Policy
In 2008, the Surgeon General’s call to action to prevent VTE declared that at least
350,000, and as many as 600,000 Americans develop VTE, and approximately 100,000
deaths are thought to be related to VTE (Office of the Surgeon General (U.S.); National
Heart, Lung, and Blood Institute (U.S.), 2008). The Centers for Medicare and Medicaid
Services (CMS, 2014a) and the Agency for Healthcare Research and Quality (AHRQ,
2014a) have reported that VTE is the most common preventable cause of hospital death.
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Postoperative VTE is a common complication of surgical procedures that can lead to
increased length of stay, excess mortality, and increased cost (Johnson & Riley, 2012).
The incidence of confirmed hospital acquired VTE ranges from 40% -60% among
orthopedic surgery patients (Johnson & Riley, 2012). Despite this, not all patients receive
an appropriate VTE prophylaxis due to a disproportionate fear of bleeding complications
(Cionac Florescu et al., 2013). Given the staggering statistics of postoperative VTE in
orthopedic surgery patients and the organization’s prior poor performance, the decision to
standardize care with the implementation of an electronic order set has demonstrated a
decrease in postoperative orthopedic VTE outcomes for total hip arthroplasty patients.
Practice
The history of the literature demonstrates that chemical thromboembolism
prophylaxis has been controversial in the prevention of postoperative VTE in orthopedic
surgery patients (AAOS, 2011b). The PEP (2000) study and ATC (2002) meta-analyses
provided strong evidence that aspirin reduces the incidence of VTE after major
orthopedic surgery. Despite these results, the AAOS and ACCP guidelines were not
consistent in their recommendations of aspirin to prevent postoperative VTE in THA
patients.
The latest VTE prevention guidelines were published by AAOS in 2011 and
ACCP in 2012. As evidence is acquired, it is important to evaluate the level of evidence
and quality (American Nurses Association, 2015). The American Nurses Association
(2015) notes there are numerous scales for levels of evidence ranging from three to seven
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levels. The definitions of levels of evidence have not been standardized (American
Nurses Association, 2015). Clinical practice guidelines published by two different
nationally recognized organizations that lack standardized levels of evidence can be
problematic for clinicians to fully appraise the evidence to prevent VTE disease in the
postoperative orthopedic population. The clinical practice guidelines published by the
AAOS and ACCP employ different levels of evidence that are not aligned in a
standardized approach. Clinicians are challenged by inconsistencies in the literature,
which may cause confusion when attempting to adopt evidence-based practices. After
thorough review of the evidence, the organization determined aspirin was appropriate
prophylaxis for postoperative orthopedic arthroplasty procedures and provider ordering
adherence has increased with the electronic order set.
Research
The results of the DNP quality improvement initiative demonstrated that
technology positively influenced VTE prophylaxis ordering adherence and reduced
postoperative orthopedic VTE outcomes. Reducing postoperative and 30 day
readmissions for VTE will have positive financial results for the hospital. According to
Kohlbrenner, Whitelaw, and Cannaday (2011) hospital-acquired VTE care costs
approximately $58,627 per case. Based on the results of the quality improvement
initiative, there were seven less VTE’s in the postelectronic order set group. This
accounts for a total of $410,704 in savings for the organization. Venous
thromboembolism is a preventable condition that requires additional research and
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analysis by the organization to ensure all patients receive appropriate prophylaxis.
Additional measures will be considered with effective system design and electronic
alerting mechanisms at the right time of care processes, delivery, and evaluation, which
can reduce and virtually eliminate a near miss for VTE prophylaxis (Streiff et al., 2014).
Social Change
The DNP quality improvement project impacted social change by decreasing the
number of patients with postoperative VTE following THA surgery. Through the
development and implementation of the project, I demonstrated the ability to appraise and
critique the evidence in the context of the orthopedic patient. The orthopedic surgeons
were very interested to learn since implementing the electronic order set that ordering
adherence to VTE prophylaxis had increased and VTE outcomes decreased. The
prevention and management of VTE continues to pose patient safety issues in most U.S.
hospitals (Duff, Walker, & Omari, 2011). The results of the project have had a positive
influence on the orthopedic surgeons because they are no longer willing to accept VTE as
a normal complication and want to provide the safest care possible. The orthopedic
surgeons have asked for their specific VTE prophylaxis ordering adherence reports and
are committed to performing case reviews when the protocol is not followed. The project
also encouraged nurses to identify when the protocol is not used and place a phone call to
the provider to discuss and obtain appropriate orders. Future social change may also
explore launching an orthopedic VTE prophylaxis campaign for patients and families to
educate them on preventing a serious post-operative complication.
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Project Strengths and Limitations
Strengths
One of the strengths of the quality improvement project is the sample size that
was evaluated for the pre and post order set time periods. According to Grove, Burns, and
Gray (2013) the sampling component is an important part of the project process that
needs to be well thought out and described clearly. Specific inclusion and exclusion
criteria were defined for the pre and postelectronic order set six month time periods that
were evaluated. A total of 325 THA cases were examined for the preelectronic order set
period of January 1 2014 through June 30 2014 and 406 THA cases were examined for
the postelectronic order set period of January 1 2015 through June 30 2015.
A second strength of the quality improvement project was that it evaluated
provider ordering adherence to VTE prophylaxis, mechanical, and pharmacological
prophylaxis. Prior to this project, this type of data was not measured by the organization
and shared with the providers. The orthopedic providers did not have knowledge of their
baseline VTE prophylaxis ordering adherence. In the absence of a baseline compliance
result, the orthopedic providers were unsure if the electronic ordering pathway would
increase or decrease their level of compliance and improve VTE outcomes. The results of
the DNP project proved that 100% ordering adherence was sustained for mechanical
prophylaxis, chemical prophylaxis ordering increased, and VTE outcomes were reduced
with implementation of the electronic order set.
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Limitations
One of the limitations of the quality improvement project was that another six
month period was not evaluated after the order set was implemented to assess if ordering
adherence continues to advance and VTE outcomes continue to decline. Conducting the
additional analysis would inform the providers and the organization if change has been
sustained and hard wired into the daily workflow of the clinician. Reliable data collection
and performance tracking is necessary for breakthrough and sustained levels of
improvement (Maynard & Stein, 2010).
Another limitation of the quality improvement project is that the project focused
only on THA cases. Orthopedic surgery is a well-established risk factor for VTE.
Assessing total knee arthroplasty cases for the same time periods may provide additional
insight into VTE ordering adherence and orthopedic VTE outcomes.
Recommendations for Remediation of Limitations in Future Work
Based on the results of the DNP quality improvement project there are several
recommendations for future doctoral work. The first opportunity is to conduct a
retrospective analysis on the VTE cases that occurred during the pre and postelectronic
order set time periods. The review may uncover risk factors that were missed that may
have led to the development of a VTE or if appropriate prophylaxis was prescribed. The
second opportunity is to integrate a VTE risk assessment and score into the electronic
order set. Incorporating a VTE risk assessment into the electronic order set would provide
transparency to nurses and other clinicians of the patient’s risk level and if the appropriate
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prophylaxis was prescribed. Lastly, developing an educational campaign for nurses,
patients, and families that VTE is an important and preventable public health concern is
needed to raise awareness. Empowering patients and families to raise the issue of
postoperative VTE with their providers may assist in preventing a negative outcome.
Venous thromboembolism prophylaxis should be determined during the pre-operative
surgical discussion with the provider and the patient. The information should accompany
the patient upon arrival to the hospital and be reviewed again after the procedure. Patient
knowledge and awareness may ensure consistent and reliable care processes in the
prevention of VTE in the postoperative orthopedic patient.
Analysis of Self
As Practitioner
Throughout the development of the project, I became more knowledgeable of
appropriate VTE prophylaxis for postoperative orthopedic patients and why orthopedic
clinicians may be reluctant to ordering. I learned that key subject matter experts were not
always familiar with recommendations from the literature and their practice may be
lagging behind. In part, I believe this is because the guidelines are difficult to read and
interpret. Often, there may be inconsistencies depending on who authored the content and
this may lead to even more confusion and delays in implementing evidence-based
practices. Simplifying the guideline content with application that is relevant to practice
may assist clinicians in examining their current practice. The American Association of
Colleges of Nursing (AACN, 2006) Essential VI, Interprofessional Collaboration for
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Improving Patient and Population Health Outcomes holds competencies of effective
communication and collaborative skills, analysis of complex practice issues, and
consultative and leadership skills with interprofessional teams to create change in health
care. The project has helped to further develop my communication and leadership skills.
Taking time to understand why clinicians may be reluctant to change allowed me the
opportunity to communicate and collaborate with them, which gave them confidence to
use the electronic order set. I learned that clinicians are faced with many changes
simultaneously and they need to have their voices heard or the changes risk being
adopted and patients may have negative outcomes. The skills acquired throughout the
DNP educational journey have prepared me to assess new evidence for integration into
practice in a timely manner. The completion of the DNP project demonstrates the
application of the DNP Essentials, which will provide the foundation for future advanced
practice work.
As Scholar
With the development of the project, I have gained expertise in navigating the
organization’s complex health care system. Applying systems thinking at both the micro
and macro levels enables the advanced-practice nurse to identify and implement new
solutions to resolve practice issues (Zaccagnini & White, 2011). Conducting in depth
literature reviews and presenting the information in a clear and succinct manner in the
context of the organizational issue facilitated my development as a scholar. Becoming
immersed in the evidence and citing relevant research studies has given me credibility
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among the orthopedic surgeons and key stakeholders of the organization. Furthermore,
the project provided a platform to incorporate DNP Essential III, Clinical Scholarship and
Analytical Methods for Evidence-Based Practice, which holds competencies to evaluate
quality improvement methodologies and the use of information technology to analyze
data from practice (AACN, 2006). The competencies are evident through the evaluation
of measuring VTE prophylaxis ordering adherence before and after implementation of
the electronic order set. Designing a quality improvement methodology to assess ordering
adherence has generated interest for orthopedic surgeons on their performance. The DNP
project analyzed data from practice and patient outcomes by extracting data from the
clinical information system and the electronic order set. The application of a scholarly
approach to the DNP project will serve as the cornerstone for future quality improvement
projects and research.
As Project Manager
The DNP project facilitated my growth as a project manager. In this capacity, I
learned how to take a project from concept through the steps of planning, designing,
implementation and evaluation. In order to stay on track with the project timeline, I have
learned to develop detailed project plans with key mile stone dates. I have also learned
that it is important to recognize that other project members may not have the same time
line in mind and this requires negotiation and compromise to meet the project
deliverables. The project supported DNP Essential IV, Information Systems/Technology
and Patient Care Technology for the Improvement and Transformation of Health Care,
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which holds competencies to extract data from clinical informatics systems and monitor
outcomes of care (AACN, 2006). The project leveraged the clinical information
embedded analytics system to analyze differences in VTE prophylaxis ordering
adherence and orthopedic VTE outcomes. I learned that when data is presented in a
meaningful way that validates if protocols are followed, the orthopedic surgeons took
notice and wanted to know who the outliers were. I learned that every key stakeholder is
important to the project’s success. The project leader is responsible to regularly
communicate the status of the project to key stakeholders. With the guidance of my
mentor, I was successful in managing the project.
Summary
The purpose of the project was to assess the difference of orthopedic VTE
occurrences in the post-operative THA patient before and after implementation of the
electronic order set. Analysis of the results indicated that after the electronic order set
was implemented, VTE occurrences decreased from 10 of 325 or 3.08% to 3 of 406 or
.74%. This represents a decrease of 2.34% in VTE occurrences for the pre and
postelectronic order set time periods. Mechanical prophylaxis ordering adherence of
100% was sustained both before and after the electronic order set was implemented.
Pharmacological prophylaxis ordering adherence was increased by 2.7% from 86.5% to
89.2% after the electronic order set was implemented. Based on these findings,
technology with standard electronic order sets has had a positive influence on ordering
adherence and reducing VTE outcomes.
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Completing the DNP project has been very rewarding and daunting. There were
times when I was completely overwhelmed and wanted to give up. I questioned if I had
enough intelligence, fortitude, patience, persistence, and tenacity to cross the finish line
of the DNP program. I really struggled with writing the literature review portion of the
paper. Deciphering the research studies was very challenging. I am glad that I persevered
because I am able to discuss the evidence in a scholarly manner. I am grateful to Dr.
Verklan for her guidance and support. Implementing conference calls every two weeks
with Dr. Verklan kept me focused and on track. There were issues with the mapping of
clinical data, which caused problems with data mining and extraction from the
organization’s electronic health record. The organization’s CMIO was able to trouble
shoot the mapping and remedy the issue. The lesson learned here is to expect the
unexpected and be prepared for technological glitches because they will happen.
Overall, I am proud that I have made it to this point. Completing the DNP
scholarly project will lay the foundation for future scholarly contributions to the nursing
profession. It has inspired me to consider other projects for the orthopedic service line
and preparing for the future of outpatient joint replacement. I am blessed with a
wonderful family and network of close friends and colleagues that supported me and
believed that I could become a Doctorate of Nursing Practice. I am looking forward to
spending more time with my family and friends.
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Section 5: Dissemination Plan
Nurses play a pivotal role in generating questions about safety and patient care.
To improve patient care, it is necessary for nurses to develop advanced knowledge and
skills to participate and lead teams that are pursuing best practices to improve patient care
(Dearholt & Dang, 2012). Evidence-based practice and the nursing process are similar in
that both are problem-solving strategies. As history has taught us, with innovation and
major change come many challenges and golden opportunities for advancing nursing
science, leadership, education, clinical practice and policy formulation, while optimizing
organizational and nursing quality indicators, patient safety, and efficiency across
systems of care (White & Dudley-Brown, 2012). Well-designed research and quality
improvement projects provide one venue for showcasing the important contribution of
nursing to major organizational change, improved quality, patient safety, efficiency, and
overall effectiveness.
There is a significant need for nurses to disseminate the findings of their evidence
to determine if a practice change is effective. My dissemination plan is to present the
findings in a PowerPoint presentation to the hospital organization study site’s orthopedic
performance improvement team (PIT). The PIT team is a large interdisciplinary team
comprised of organizational senior leaders, orthopedic surgeons, physician assistants,
nurses, physical and occupational therapists, quality improvement specialists, discharge
planners, pharmacists, and informatics nurses.
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The next level of dissemination is to present a poster presentation at the
organization’s nursing day of inquiry. The nursing day of inquiry is an annual event that
was developed to support nurses’ translation of new scientific evidence into clinical
practice. Nurses from across the health care system come together to share and
disseminate the findings of their research and quality improvement projects.
Lastly, the next level of dissemination is to write a scholarly article for
publication in a professional journal. At a later date, I will explore Computers,
Informatics and Nursing (CIN) or The Journal of Arthroplasty as possible professional
journals to publish in. A supplemental PowerPoint document will be provided, which
details the plan to disseminate the scholarly work product.
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